Manali Bhave, MD

• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

  • Phase

    III
  • Conditions

    Breast Neoplasms
  • Location

    Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Grady Health System, Winship Cancer Institute

• Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

  • Phase

    I
  • Conditions

    Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer), Pancreatic Adenocarcinoma, NSCLC Non-small Cell Lung Cancer, Squamous Cell Cancer of the Head and Neck, UC (Urothelial Cancer), MSI-H Cancer
  • Location

    Emory University Hospital Midtown, Winship Cancer Institute

• Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer

  • Phase

    N/A
  • Conditions

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Chemotherapy-Induced Peripheral Neuropathy, Early Stage Breast Carcinoma, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8
  • Location

    Emory University Hospital Midtown, Winship Cancer Institute

• Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

  • Phase

    II
  • Conditions

    Breast Cancer
  • Location

    Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute

• DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)

  • Phase

    II
  • Conditions

    Breast Cancer
  • Location

    Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Grady Health System, Winship Cancer Institute

Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study.

Clinical cancer research : an official journal of the American Association for Cancer Research

Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States.

Breast cancer research and treatment

Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma.

European journal of nuclear medicine and molecular imaging

Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice.

Breast cancer research and treatment

Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers.

The Journal of clinical investigation

Monitoring of Triple Negative Breast Cancer After Neoadjuvant Chemotherapy.

Clinical breast cancer

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial.

Annals of oncology : official journal of the European Society for Medical Oncology

A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Based Response Assessment.

Clinical nuclear medicine

Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical Center.

Clinical breast cancer

A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and Adnexa.

Clinical nuclear medicine

Spatially variant immune infiltration scoring in human cancer tissues.

NPJ precision oncology

Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy.

Translational lung cancer research

Cancer immunotherapy in a neglected population: The current use and future of T-cell-mediated checkpoint inhibitors in organ transplant patients.

Cancer treatment reviews

04/15/2025

She is very considerate, a good listener and seems very thorough with broad knowledge of treatment options and pros and cons.

02/09/2025

My doctor, Dr. Bhave is amazingly attentive, empathetic, sympathetic as a human being, and highly competent in her field with unmatched bedside manner. I've been seeing her for almost four years now and I feel like she single-handedly extended my lifespan with her treatments and the appropriate medications she prescribed for me. I cannot thank her enough. She is a treasure to the establishment.

02/06/2025

Bhave is wonderful, check in system not so good this time with table around the corner involved.

01/19/2025

Dr. Bhave is just a wonderful person and Dr..

01/04/2025

Dr. Bhave is wonderful! She looks you in the eye, explaines everything thoroughly, and answers all of my questions.

12/26/2024

So blessed to have a physician of such compassion and expertise!

12/08/2024

Dr. Bhave is a knowledgeable physician who is cordial and sensitive to my concerns.

12/05/2024

Absolutely recommend

11/23/2024

Dr. Bhave is awesome as always!!

11/09/2024

Dr. Bhave is THE BEST!! I'll go to her as long as she stays at Emory.

11/09/2024

Dr. Bhave's bedside manners are caring and very detailed.

11/02/2024

Good

09/27/2024

Dr Bhave is an awesome doctor she has genuine care for you.

09/27/2024

Dr, Bhave ( Outstanding Medical Professional) Kayla / NP ( Highly Skilled / Outstanding ) Highly recommend to others.

09/22/2024

Good

09/14/2024

They took their time and answered all of my questions- such a gift.

08/31/2024

They took their time with me. Answered all of my questions.

08/22/2024

Dr. Behave is very compassionate and helpful.

08/17/2024

Love Dr Bhave and nurses

08/17/2024

Dr. Bhave is excellent.

07/06/2024

Excellent team: Dr Bhavi and staff,Bobbie, and Monique.

06/22/2024

Dr Bhave apologized for lateness of meeting and I really appreciated the effort and consideration. She listened to my suggestions and was considerate of all my ideas for treatment while I wanted to be cautious of side effects. I also wanted to suggest a more Natural Homeopathic form of treatment to avoid any problems or complications from pharmaceutical drug side-effects because of my age and medical conditions. I was never informed that Anastrozole increased complications with Arthritis. I suffer from Chronic Arthritis and want to avoid it at all costs!

06/16/2024

I am very fortunate I believe to have been assigned to Dr Bhave. Her care is amazing!!!

06/06/2024

Dr Bhave is one of the best. She was so nice. Her smile snd concerns was great. Very detail in explaining results.

05/27/2024

Thr doctor was very concerned about the reactions I was having to the medication

05/25/2024

Dr Bhave is kind and very caring. She listens, understands and explains things in a way you really understand what's happening. She is absolutely wonderful!!!

05/24/2024

Dr. Bhave is always a joy to see! And her resident assistant (I am bad with names but I think it was Mohammed) was great!

05/24/2024

Dr.Bhave and her staff were phenomenal in what they were doing. They go above and beyond discussing every issue on the stage and condition of the disease plus going into social issues. Exceptionally satisfied.

05/18/2024

Dr. Bhave is the Absolute Best. She's caring, she listens and will tell you the truth. She's so good that with bad news you'll feel like she has your best interest and your back.